Skip to content
OpenCapital
Get started

Rhythm Pharmaceuticals, Inc. RYTM Market capitalization

Market capitalization at other companies

Eli Lilly logo
Eli LillyLLY
$821.68B+10.8%
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
$5.57B+152%
Arrowhead Research logo
Arrowhead ResearchARWR
$8.78B+402%
Alkermes logo
AlkermesALKS
$5.89B+9.7%
Praxis Precision Medicines, Inc. logo
Praxis Precision Medicines, Inc.PRAX
$8.97B+1,075%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$14.4B+119%

Other financials

Income statement

See full
Revenue$60.1M+83.8%
Gross profit$53.0M+82.3%
Operating income-$52.4M-11.4%
Net income-$55.6M-12.4%
EPS (diluted)-$0.83-2.5%

Balance sheet

See full
Cash & equivalents$62.1M-41.4%
Total debt$112.3M-1.1%
Total equity$122.9M+549%
Total assets$442.3M+14.4%

Cash flow

See full
Operating cash flow-$44.2M-9.5%
CapEx$238.3K—
Free cash flow-$29.2M-2.4%

Valuation

See full
Enterprise value$6.69B+78.4%
P/S30.6×+3.2×

Profitability

See full
Gross margin89.4%-0.2pp
Operating margin-90.9%-19.8pp
Net margin-93.3%-18.2pp
FCF margin-61.5%-14.1pp

Returns & leverage

See full
Return on equity-285.8%-68.9pp
Debt / equity0.9×-5.1×
Current ratio4.2×+0.9×

Where this comes from

Computed from the period-end share price: $5.94B.

The official record: Rhythm Pharmaceuticals, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rhythm Pharmaceuticals, Inc.'s market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Rhythm Pharmaceuticals, Inc.'s market capitalization?
Rhythm Pharmaceuticals, Inc. (RYTM) reported market capitalization of $5.94B in Q1 2026.
How has Rhythm Pharmaceuticals, Inc.'s market capitalization changed year-over-year?
Rhythm Pharmaceuticals, Inc.'s market capitalization increased by 77.3% year-over-year, from $3.35B to $5.94B.
What is the long-term trend for Rhythm Pharmaceuticals, Inc.'s market capitalization?
Over 5 years (2020 to 2025), Rhythm Pharmaceuticals, Inc.'s market capitalization has grown at a 36.7% compound annual growth rate (CAGR), from $1.49B to $7.14B.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.